The Food and Drug Administration (FDA) recently gave approval for clinical trials in the U.S. of a COVID-19 nasal vaccine ...

The Trump administration's "short pause" on communications, expected to end on Feb. 1, has affected FDA updates on food ...

The biosimilar will be available in both subcutaneous and intravenous formulations and has nearly all the same indications as ...

When politicians subordinate scientific institutions to electoral interests, they undermine immediate public health efforts ...

Federal regulators have warned a Waco company that its human amniotic products are “unlicensed” and “unapproved,” and that ...

Avtozma, the third biosimilar to Actemra, has received FDA approval for multiple inflammatory diseases and COVID-19, ...

The U.S. Food and Drug Administration has approved the first-ever clinical trials testing pig kidney transplants in people ...

Even a mild infection with COVID-19 can promote clogged arteries, increasing the risk of heart attack in some people, a new ...

Ahead of Robert F. Kennedy Jr.’s confirmation hearings, experts—and RFK’s own family—expressed concerns about his ...

Here’s what to know about the Trump administration’s order and which information is still available to California residents.

“It’s unconscionable that more than four years since this began, we still don’t have one FDA-approved drug,” said Meighan ...